Cargando…
Design and In Silico Validation of a Novel MZF-1-Based Multi-Epitope Vaccine to Combat Metastatic Triple Negative Breast Cancer
Immunotherapy is emerging as a potential therapeutic strategy for triple negative breast cancer (TNBC) owing to the immunogenic landscape of its tumor microenvironment. Interestingly, peptide-based cancer vaccines have garnered a lot of attention as one of the most promising cancer immunotherapy reg...
Autores principales: | Krishnamoorthy, HemaNandini Rajendran, Karuppasamy, Ramanathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051597/ https://www.ncbi.nlm.nih.gov/pubmed/36992161 http://dx.doi.org/10.3390/vaccines11030577 |
Ejemplares similares
-
Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach
por: Rajendran Krishnamoorthy, HemaNandini, et al.
Publicado: (2022) -
Envelope Glycoprotein based multi-epitope vaccine against a co-infection of Human Herpesvirus 5 and Human Herpesvirus 6 using in silico strategies
por: Gandhamaneni, Bharath Sai, et al.
Publicado: (2022) -
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach
por: Paranthaman, Priyanga, et al.
Publicado: (2023) -
hMZF-2, the Elusive Transcription Factor
por: Chebly, Alain, et al.
Publicado: (2020) -
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression
por: Fang, Erhu, et al.
Publicado: (2020)